Advances in Interventional Radiology for Oncological Management
A special issue of Current Oncology (ISSN 1718-7729).
Deadline for manuscript submissions: 31 July 2026 | Viewed by 55
Special Issue Editors
Interests: interventional radiology
Special Issue Information
Dear Colleagues,
This Special Issue of Interventional Oncology will highlight the rapidly evolving role of minimally invasive image-guided therapies in cancer care. Interventional oncology (IO) has emerged as the “fourth pillar” of oncology, complementing surgery, medical oncology, and radiation oncology. This Special Issue will cover cutting-edge techniques including tumor ablation, embolization, and advanced catheter-directed therapies, alongside their integration into systemic treatments such as immunotherapy and targeted agents. We will explore novel technologies, imaging biomarkers, and AI-driven solutions to enhance precision, efficacy, and safety. Contributions will emphasize clinical outcomes, translational research, multidisciplinary collaboration, and future directions in IO. By gathering perspectives from leading experts, this Special Issue will provide a comprehensive overview of current innovations and chart a path forward in the effort to improve survival and quality of life in patients with cancer.
Dr. Alex L. Wallace
Dr. Merve Ozen
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- interventional oncology
- tumor ablation
- embolization
- image-guided therapy
- personalized medicine
- translational research
- cancer care
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
